Corrigendum: Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancer

Saved in:
Bibliographic Details
Main Authors: Qinyuan Gong, Rongzhen Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1560546/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832581917088677888
author Qinyuan Gong
Qinyuan Gong
Rongzhen Xu
Rongzhen Xu
author_facet Qinyuan Gong
Qinyuan Gong
Rongzhen Xu
Rongzhen Xu
author_sort Qinyuan Gong
collection DOAJ
format Article
id doaj-art-c2bf75041deb4678972149a0b1bf56d8
institution Kabale University
issn 1664-3224
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-c2bf75041deb4678972149a0b1bf56d82025-01-30T09:24:52ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-01-011610.3389/fimmu.2025.15605461560546Corrigendum: Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancerQinyuan Gong0Qinyuan Gong1Rongzhen Xu2Rongzhen Xu3Department of Hematology and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaInstitute of Hematology, Zhejiang University, Hangzhou, ChinaDepartment of Hematology and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaInstitute of Hematology, Zhejiang University, Hangzhou, Chinahttps://www.frontiersin.org/articles/10.3389/fimmu.2025.1560546/fullcancer immunosuppressionendogenous retrovirusesHML-2 subtypeHERV-K102serum biomarker
spellingShingle Qinyuan Gong
Qinyuan Gong
Rongzhen Xu
Rongzhen Xu
Corrigendum: Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancer
Frontiers in Immunology
cancer immunosuppression
endogenous retroviruses
HML-2 subtype
HERV-K102
serum biomarker
title Corrigendum: Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancer
title_full Corrigendum: Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancer
title_fullStr Corrigendum: Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancer
title_full_unstemmed Corrigendum: Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancer
title_short Corrigendum: Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancer
title_sort corrigendum subtype specific human endogenous retrovirus k102 envelope protein is a novel serum immunosuppressive biomarker of cancer
topic cancer immunosuppression
endogenous retroviruses
HML-2 subtype
HERV-K102
serum biomarker
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1560546/full
work_keys_str_mv AT qinyuangong corrigendumsubtypespecifichumanendogenousretrovirusk102envelopeproteinisanovelserumimmunosuppressivebiomarkerofcancer
AT qinyuangong corrigendumsubtypespecifichumanendogenousretrovirusk102envelopeproteinisanovelserumimmunosuppressivebiomarkerofcancer
AT rongzhenxu corrigendumsubtypespecifichumanendogenousretrovirusk102envelopeproteinisanovelserumimmunosuppressivebiomarkerofcancer
AT rongzhenxu corrigendumsubtypespecifichumanendogenousretrovirusk102envelopeproteinisanovelserumimmunosuppressivebiomarkerofcancer